| Q77068471 | A unique xanthine derivative KMCP-98 with activation of adenosine receptor subtypes |
| Q77619963 | Adenosine A1-receptor occupancy predicts A1-receptor antagonist effects of N-0861 |
| Q84308346 | Adenosine receptors and asthma |
| Q24644125 | Adenosine receptors and asthma in humans |
| Q53229500 | Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. |
| Q28139810 | Aminophylline in the treatment of atropine-resistant bradyasystole |
| Q35601417 | Contributions of A2A and A2B adenosine receptors in coronary flow responses in relation to the KATP channel using A2B and A2A/2B double-knockout mice |
| Q42545723 | Correlation between hemodynamic changes and tomographic sestamibi imaging during dipyridamole-induced coronary hyperemia |
| Q90148744 | Guillain-Barré syndrome presenting with an 'angina' mimic and posterior reversible encephalopathy syndrome |
| Q28279556 | Highlights on the development of A(2A) adenosine receptor agonists and antagonists |
| Q43087833 | Lessons from regadenoson and low-level treadmill/regadenoson myocardial perfusion imaging: initial clinical experience in 1263 patients |
| Q36110561 | Myocardial ischaemia and cardiac pain - a mysterious relationship |
| Q41531517 | Myocardial perfusion imaging during adenosine-induced coronary hyperemia |
| Q35097850 | Pharmacologic stress testing: new methods and new agents |